Abstract
A chronic, life threatening and immuno-suppressing malady caused by Human immunodeficiency virus (HIV) is formally known as Acquired Immune Deficiency Syndrome (AIDS). Currently, combinations of several anti-retroviral drugs are being used for the management of HIV infection. These drugs possess certain limitations and hence researchers across the globe are striving to explore treatment methodologies based on medicinal plants of natural origin in order to develop safe and effective treatment. In this review, various medicinal plants are categorized on the basis of target of action namely Reverse transcriptase enzyme, Protease enzyme, Integrase enzyme, cell fusion, CC chemokine receptor 5 (CCR5) CXC chemokine receptor 4 (CXCR4). Medicinal plants exhibiting multi-targeted activities against various targets of HIV are also reviewed. Detail description of medicinal plants with their habitat, common names, category of systems of medicines, phytoconstituents and their biological activities in terms of relative % inhibition or IC50 or EC50 are provided in this review. Anti-HIV benefits of these plants are observed due to phytoconstituents like terpenoids, tannins, alkaloids, polyphenols, coumarins, flavonoids, etc. In order to gain the structural knowledge for future developments of anti-HIV leads, ligand based pharmacophore was generated using phytoconstituents mentioned in this review. Structural modifications of these phytoconstituents on hydrophobic, donor and acceptor regions are beneficial for the potent anti-HIV activity. In conclusion, this study may prove to be a stepping stone towards the use of herbal medicinal plants for the management of HIV/AIDS and may aspire researchers to look for new treatment options from the natural sources.
Graphical abstract
Similar content being viewed by others
Abbreviations
- HIV:
-
Human immunodeficiency virus
- AIDS:
-
Acquired immune deficiency syndrome
- RT:
-
Reverse transcriptase
- PR:
-
Protease
- IN:
-
Integrase
- CCR5:
-
CC chemokine receptor 5
- CXCR4:
-
Chemokine receptor 4 (CXCR4)
- % IR:
-
Relative percent inhibition
References
Ahn M-J, Kim CY, Lee JS et al (2002) Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. Planta Med 68(5):457–459
Al-Snafi AE (2015) The pharmacological importance of Ailanthus altissima-A review. Int J Pharm Rev Res 5(2):121–129
Alasbahi RH, Melzig MF (2010a) Plectranthus barbatus: a review of phytochemistry, ethnobotanical uses and pharmacology–part 2. Planta Med 76(8):753–765
Alasbahi RH, Melzig MF (2010b) Plectranthus barbatus: a review of phytochemistry, ethnobotanical uses and pharmacology–part 1. Planta Med 76(7):653–661
Amalraj A, Gopi S (2017) Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: a review. J Tradit Complement Med (1): 65–78
Anjaneyulu ASR, Prasad AVR (1983) Structure of terminic acid, a dihydroxytriterpene carboxylic acid from Terminalia arjuna. Phytochemistry 22(4):993–998
Au TK, Lam TL, Ng TB et al (2001) A comparison of HIV-1 integrase inhibition by aqueous and methanol extracts of Chinese medicinal herbs. Life Sci 68(14):1687–1694
Bartlett JA, Shao JF (2009) Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. Lancet Infect Dis 9(10):637–649
Basavaraj KH, Navya MA, Rashmi R (2010) Quality of life in HIV/AIDS. Indian J Sex Transm Dis AIDS 31(2):75
Behbahani M (2014) Evaluation of anti-HIV-1 activity of a new iridoid glycoside isolated from Avicenna marina, in vitro. Int Immunopharmacol 23(1):262–266
Bhatt H, Patel P, Pannecouque C (2014a) Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation. Chem Biol Drug Des 83(2):154–166
Bodiwala HS, Sabde S, Mitra D, et al (2009) Anti-HIV Diterpenes from Coleus forskohlii. Nat Prod Commun 4(9): 1934578X0900400902
Boireau S, Maiuri P, Basyuk E et al (2007) The transcriptional cycle of HIV-1 in real-time and live cells. J Cell Biol 179(2):291–304
Braca A, Sinisgalli C, De Leo M, et al (2018) Phytochemical profile, antioxidant and antidiabetic activities of Adansonia digitata L.(Baobab) from Mali, as a source of health-promoting compounds. Molecules 23(12): 3104
Brinkworth RI, Stoermer MJ, Fairlie DP (1992) Flavones are inhibitors of HIV-1 proteinase. Biochem Biophys Res Commun 188(2):631–637
Bunluepuech K, Tewtrakul* S (2011) Anti-HIV-1 integrase activity of Thai medicinal plants in longevity preparations. Sonklanakarin J Sci Technol 33(6): 693
Cagigi A, Mowafi F, Phuong Dang LV et al (2008) Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood 112(12):4401–4410
de Castro S, Camarasa M-J (2018) Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy? Eur J Med Chem 150:206–227
Chang Y, Woo E (2003) Korean medicinal plants inhibiting to Human Immunodeficiency Virus type 1 (HIV-1) fusion. Phyther Res an Int J Devoted to Pharmacol Toxicol Eval Nat Prod Deriv 17(4):426–429
Chang RS, Yeung HW (1988) Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs. Antiviral Res 9(3):163–175
Chaniad P, Wattanapiromsakul C, Pianwanit S, Tewtrakul S (2016) Anti-HIV-1 integrase compounds from Dioscorea bulbifera and molecular docking study. Pharm Biol 54(6):1077–1085
Chinnaiyan SK, Subramanian MR, Kumar SV, et al (2013) Antimicrobial and anti-HIV activity of extracts of Canthium coromandelicum (Burm. f.) Alston leaves. J Pharm Res 7(7): 588–594
Cihlar T, Ray AS (2010) Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antiviral Res 85(1):39–58
Degroote S, Vogelaers D, Vandijck DM et al (2014) What determines health-related quality of life among people living with HIV: an updated review of the literature. Arch Public Heal 72:1–10
Dinda B, Das SK, Hajra AK, et al (2019) Chemical constituents of Plumbago indica roots and reactions of plumbagin: Part II
Dragic T, Litwin V, Allaway GP et al (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381(6584):667–673
El-Mekkawy S, Meselhy MR, Kusumoto IT, et al (1995) Inhibitory effects of egyptian folk medicines oh human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull 43(4):641–648
Esposito F, Mandrone M, Del Vecchio C, et al (2017) Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action. Pathog Dis 75(6): ftx065
Feng Y, Li X, Duan X, Wang B (2006) Iridoid glucosides and flavones from the aerial parts of Avicennia marina. Chem Biodivers 3(7):799–806
Ganbold M, Barker J, Ma R et al (2010) Cytotoxicity and bioavailability studies on a decoction of Oldenlandia diffusa and its fractions separated by HPLC. J Ethnopharmacol 131(2):396–403
Ghosh AK, Osswald HL, Prato G (2016) Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV/AIDS. J Med Chem 59(11):5172–5208
Group W-H (2003) Preliminary development of the World Health Organsiation’s Quality of Life HIV instrument (WHOQOL-HIV): analysis of the pilot version. Soc Sci Med 57(7): 1259–1275
Gu X, Li Y, Mu J, Zhang Y (2013) Chemical constituents of Prunella vulgaris. J Environ Sci 25:S161–S163
Hamarsheh O (2020) HIV/AIDS in palestine: a growing concern. Int J Infect Dis 90:18–20
Han L, Liu E, Kojo A, et al (2015) Qualitative and quantitative analysis of Eclipta prostrata L. by LC/MS. Sci World J
Haque N, Sofi G, Ali W et al (2015) A comprehensive review of phytochemical and pharmacological profile of Anar (Punica granatum Linn): a heaven’s fruit. J Ayurvedic Herb Med 1(1):22–26
Hegde S, Hegde HV, Jalalpure SS et al (2017) Resolving identification issues of Saraca asoca from its adulterant and commercial samples using phytochemical markers. Pharmacogn Mag 13:S266
Hoenigl M, Green N, Camacho M et al (2016) Signs or symptoms of acute HIV infection in a cohort undergoing community-based screening. Emerg Infect Dis 22(3):532
Honda T, Murae T, Tsuyuki T, et al (1976) Arjungenin, arjunglucoside I, and arjunglucoside II. A new triterpene and new triterpene glucosides from Terminalia arjuna. Bull Chem Soc Jpn 49(11): 3213–3218
Hong Z-L, Xiong J, Wu S-B et al (2013) Tetracyclic triterpenoids and terpenylated coumarins from the bark of Ailanthus altissima (“Tree of Heaven”). Phytochemistry 86:159–167
https://indiabiodiversity.org/. Accessed on 21th April 2020
https://eol.org/. Accessed on 21th April 2020
https://aidsinfo.unaids.org/. Accessed on 12th March 2020.
Hussein G, Miyashiro H, Nakamura N et al (1999) Inhibitory effects of Sudanese plant extracts on HIV-1 replication and HIV-1 protease. Phyther Res an Int J Devoted to Pharmacol Toxicol Eval Nat Prod Deriv 13(1):31–36
Kalinina OV, Pfeifer N, Lengauer T (2013) Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism. Retrovirology 10(1):1–11
Kapewangolo P, Hussein AA, Meyer D (2013) Inhibition of HIV-1 enzymes, antioxidant and anti-inflammatory activities of Plectranthus barbatus. J Ethnopharmacol 149(1):184–190
Kirchhoff F (2013) HIV life cycle: overview. Encyclopedia of AIDS, 1–9
Kojima H, Ogura H (1986) Triterpenoids from Prunella vulgaris. Phytochemistry 25(3):729–733
Kumbhar ST, Patil SP, Une HD (2018) Phytochemical analysis of Canna indica L. roots and rhizomes extract. Biochem Biophys Rep 16: 50–55
Kusumoto IT, Nakabayashi T, Kida H et al (1995) Screening of various plant extracts used in ayurvedic medicine for inhibitory effects on human immunodeficiency virus type 1 (HIV-1) protease. Phyther Res 9(3):180–184
Lam TL, Lam ML, Au TK et al (2000) A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extracts of Chinese medicinal herbs. Life Sci 67(23):2889–2896
Laure F, Raharivelomanana P, Butaud J-F et al (2008) Screening of anti-HIV-1 inophyllums by HPLC–DAD of Calophyllum inophyllum leaf extracts from French Polynesia Islands. Anal Chim Acta 624(1):147–153
Lee-Huang S, Kung H, Huang PL et al (1991) A new class of anti-HIV agents: GAP31, DAPs 30 and 32. FEBS Lett 291(1):139–144
Levy JA, Mackewicz CE, Barker E (1996) Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 17(5):217–224
Li X-C, Liu C, Yang L-X, Chen R-Y (2011) Phenolic compounds from the aqueous extract of Acacia catechu. J Asian Nat Prod Res 13(9):826–830
Li X, Wang H, Liu C, Chen R (2010) Chemical constituents of Acacia catechu. Zhongguo Zhong yao za zhi= Zhongguo zhongyao zazhi= China journal of Chinese materia medica 35(11): 1425–1427
Liang Z, He M, Fong W, et al (2008) A comparable, chemical and pharmacological analysis of the traditional Chinese medicinal herbs Oldenlandia diffusa and O. corymbosa and a new valuation of their biological potential. Phytomedicine 15(4): 259–267
Maartens G, Celum C, Lewin SR (2014) HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet 384(9939):258–271
Mahmood N, Piacente S, Pizza C et al (1996) The anti-HIV activity and mechanisms of action of pure compounds isolated fromRosa damascena. Biochem Biophys Res Commun 229(1):73–79
Martins N, Petropoulos S, Ferreira ICFR (2016) Chemical composition and bioactive compounds of garlic (Allium sativum L.) as affected by pre-and post-harvest conditions: a review. Food Chem 211: 41–50
Matsuse IT, Lim YA, Hattori M, et al (1998) A search for anti-viral properties in Panamanian medicinal plants.: the effects on HIV and its essential enzymes. J Ethnopharmacol 64(1): 15–22
Modi M, Dezzutti CS, Kulshreshtha S et al (2013) Extracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat. Virol J 10(1):1–17
Moore RC, Fazeli PL, Jeste DV et al (2014) Successful cognitive aging and health-related quality of life in younger and older adults infected with HIV. AIDS Behav 18(6):1186–1197
Muanza DN, Euler KL, Williams L, Newman DJ (1995) Screening for antitumor and anti-HIV activities of nine medicinal plants from Zaire. Int J Pharmacogn 33(2):98–106
Nakane H, Arisawa M, Fujita A et al (1991) Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives. FEBS Lett 286(1–2):83–85
Narayan C, Rai RV, Tewtrakul S (2011) A screening strategy for selection of anti-HIV-1 integrase and anti-HIV-1 protease inhibitors from extracts of Indian medicinal plants. Int J Phytomedicine 3(3):312
Niranjan Reddy VL, Malla Reddy S, Ravikanth V et al (2005) A new bis-andrographolide ether from Andrographis paniculata nees and evaluation of anti-HIV activity. Nat Prod Res 19(3):223–230
Oh C, Price J, Brindley MA et al (2011) Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L. Virol J 8(1):1–10
Ono K, Nakane H, Fukushima M et al (1990) Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem 190(3):469–476
Panthong P, Bunluepuech K, Boonnak N et al (2015) Anti-HIV-1 integrase activity and molecular docking of compounds from Albizia procera bark. Pharm Biol 53(12):1861–1866
Patel PK, Bhatt HG (2020) Improved 3D-QSAR prediction by multiple-conformational alignments and molecular docking studies to design and discover HIV-I protease inhibitors. Curr HIV Res 19(2):154–171
Patel PK, Bhatt HG (2021) Improved 3D-QSAR prediction by multiple conformational alignments and molecular docking studies to design and discover HIV-I protease inhibitors. Curr HIV Res 19(2):154–171
Patel SB, Patel BD, Pannecouque C, Bhatt HG (2016) Design, synthesis and anti-HIV activity of novel quinoxaline derivatives. Eur J Med Chem 117:230–240
Patil AD, Freyer AJ, Eggleston DS et al (1993) The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree. Calophyllum Inophyllum Linn J Med Chem 36(26):4131–4138
Patro SK, Sasmal D (2015) Invitro Antioxidant study and search for a novel bioactive compound from leave fractions of canthium coromandelicum (Burm. F.) Alston. Int J Pharm Sci Res 6(9): 3841
Pawar KD, Joshi SP, Bhide SR, Thengane SR (2007) Pattern of anti-HIV dipyranocoumarin expression in callus cultures of Calophyllum inophyllum Linn. J Biotechnol 130(4):346–353
Pelay-Gimeno M, Glas A, Koch O, Grossmann TN (2015) Structure-based design of inhibitors of protein–protein interactions: mimicking peptide binding epitopes. Angew Chemie Int Ed 54(31):8896–8927
Pengsuparp T, Cai L, Constant H et al (1995) Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase. J Nat Prod 58(7):1024–1031
Pironti A, Pfeifer N, Kaiser R et al (2014) Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences. J Int AIDS Soc 17:19743
Psotová J, Kolář M, Soušek J et al (2003) Biological activities of Prunella vulgaris extract. Phyther Res an Int J Devoted Pharmacol Toxicol Eval Nat Prod Deriv 17(9):1082–1087
Puripattanavong J, Tungcharoen P, Chaniad P et al (2016) Anti-HIV-1 integrase effect of compounds from Aglaia andamanica leaves and molecular docking study with acute toxicity test in mice. Pharm Biol 54(4):654–659
Ranasinghe RA, Maduwanthi SD, Marapana RA (2019) Nutritional and health benefits of jackfruit (Artocarpus heterophyllus Lam.): a review. Int J Food Sci 4327183
Rashid MA, Gustafson KR, Kashman Y et al (1995) Anti-HIV alkaloids from Toddalia asiatica. Nat Prod Lett 6(2):153–156
Rimando AM, Pezzuto JM, Farnsworth NR et al (1994) New lignans from Anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity. J Nat Prod 57(7):896–904
Rodriguez-Penney AT, Iudicello JE, Riggs PK et al (2013) Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS 27:5–16
Row LR, Murty PS, Rao GSRS, et al (1970) Chemical examination of Terminalia species. XII. Isolation & structure determination of arjunic acid, a new trihydroxytriterpene carboxylic acid from Terminalia arjuna bark. Indian J Chem 8: 716–721
Ryu SY, Lee C-K, Lee CO et al (1992) Antiviral triterpenes from Prunella vulgaris. Arch Pharm Res 15(3):242–245
Sabde S, Bodiwala HS, Karmase A et al (2011) Anti-HIV activity of Indian medicinal plants. J Nat Med 65(3–4):662–669
Salehi B, Kumar NVA, Şener B et al (2018) Medicinal plants used in the treatment of human immunodeficiency virus. Int J Mol Sci 19(5):1459
Scarlatti G, Tresoldi E, Björndal Å et al (1997) In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 3(11):1259–1265
Senapati SK, Das GK, Aparajita S, Rout GR (2012) Assessment of genetic variability in the Asoka tree of India. Biodiversity 13(1):16–23
Sharma A, Rangari V (2016) HIV-1 reverse transcriptase and protease assay of methanolic extracts of Adansonia digitata L. Int J Pharm Pharm Sci 8:124–127
Shirolkar A, Gahlaut A, Chhillar AK, Dabur R (2013) Quantitative analysis of catechins in Saraca asoca and correlation with antimicrobial activity. J Pharm Anal 3(6):421–428
Silprasit K, Seetaha S, Pongsanarakul P et al (2011) Anti-HIV-1 reverse transcriptase activities of hexane extracts from some Asian medicinal plants. J Med Plants Res 5(19):4899–4906
Simon V, Ho DD, Karim QA (2006) HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 368(9534):489–504
Singh B, Singh VP, Pandey VB, Rücker G (1995) A new triterpene glycoside from Terminalia arjuna. Planta Med 61(6):576–577
Singh DV, Verma RK, Gupta MM, Kumar S (2002a) Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem Anal an Int J Plant Chem Biochem Tech 13(4):207–210
Singh DV, Verma RK, Singh SC, Gupta MM (2002b) RP-LC determination of oleane derivatives in Terminalia arjuna. J Pharm Biomed Anal 28(3–4):447–452
Srivastava GN, Bagchi GD, Srivastava AK (1988) Pharmacognosy of Ashoka stem bark and its adulterants. Int J Crude Drug Res 26(2):65–72
Suchitra M, Cheriyan BV (2018) Vitex trifolia: an ethnobotanical and pharmacological review. Asian J Pharm Clin Res 11(4):12–14
Tabba HD, Chang RS, Smith KM (1989) Isolation, purification, and partial characterization of prunellin, an anti-HIV component from aqueous extracts of Prunella vulgaris. Antiviral Res 11(5–6):263–273
Tandon N, Yadav SS (2017) Contributions of Indian Council of Medical Research (ICMR) in the area of Medicinal plants/Traditional medicine. J Ethnopharmacol 197:39–45
Tewtrakul S, Subhadhirasakul S, Cheenpracha S, Karalai C (2007) HIV-1 protease and HIV-1 integrase inhibitory substances from Eclipta prostrata. Phyther Res an Int J Devoted Pharmacol Toxicol Eval Nat Prod Deriv 21(11):1092–1095
Tewtrakul S, Subhadhirasakul S, Kummee S (2006) Anti-HIV-1 integrase activity of medicinal plants used as self medication by AIDS patients. Songklanakarin J Sci Technol 28(4):785–790
Tobyn G, Denham A, Whitelegg M (2016) The Western herbal tradition: 2000 years of medicinal plant knowledge. Singing Dragon
Vernekar SKV, Liu Z, Nagy E et al (2015) Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1, 3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities. J Med Chem 58(2):651–664
Wang W, Ali Z, Shen Y et al (2010) Ursane triterpenoids from the bark of Terminalia arjuna. Fitoterapia 81(6):480–484
Wang J-N, Hou C-Y, Liu Y-L et al (1994) Swertifrancheside, an HIV-reverse transcriptase inhibitor and the first flavone-xanthone dimer, from Swertia franchetiana. J Nat Prod 57(2):211–217
Wang CF, Li JP, Zhang YB, Zhang ZZ (2011) Chemical constituents from the roots of Senecio scandens. Chem Nat Compd 47(2):243–245
Wilen CB, Tilton JC, Doms RW (2012) HIV: cell binding and entry. Cold Spring Harb Perspect Med 2(8):a006866
Woradulayapinij W, Soonthornchareonnon N, Wiwat C (2005) In vitro HIV type 1 reverse transcriptase inhibitory activities of Thai medicinal plants and Canna indica L. rhizomes. J Ethnopharmacol 101(1–3): 84–89
Xu H, Wan M, Loh B et al (1996) Screening of traditional medicines for their inhibitory activity against HIV-1 protease. Phyther Res 10:207–210
Xu Z, Zhao S-J, Lv Z-S et al (2019) Fluoroquinolone-isatin hybrids and their biological activities. Eur J Med Chem 162:396–406
Yadav M, Sehrawat A, Kumar D, Bhidhasra A (2017) Therapeutic plants and phytoconstituents as natural anti-HIV agents: a review. Inven Rapid Planta Act 2017:1–5
Yao X-J, Wainberg MA, Parniak MA (1992) Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris. Virology 187(1):56–62
Zaitseva E, Zaitsev E, Melikov K et al (2017) Fusion stage of HIV-1 entry depends on virus-induced cell surface exposure of phosphatidylserine. Cell Host Microbe 22(1):99–110
Acknowledgements
The authors PKP and HGB are thankful to Nirma University, Ahmedabad, India for providing necessary facilities to carry out the work, which is a part of Doctor of Philosophy (Ph.D.) research work of Mr. Paresh Patel, to be submitted to Nirma University, Ahmedabad, India. The authors DVP, SRS and PKP are also thankful to L. J. Institute of Pharmacy, L J University, Ahmedabad, India for providing necessary support.
Funding
No funding source has been utilized in this work.
Author information
Authors and Affiliations
Contributions
DVP, SRS and PKP carried out literature search, compilation of data and preparation of manuscript. HGB & PKP supervised the work and revised the manuscript.
Corresponding author
Ethics declarations
Ethical statement
This article does not contain any studies involving animals performed by any of the authors. This article does not contain any studies involving human participants performed by any of the authors.
Conflict of interest
Dharmraj V. Pathak has no conflict of interest. Sneha R. Sagar has no conflict of interest. Hardik G. Bhatt has no conflict of interest. Paresh K. Patel has no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pathak, D.V., Sagar, S.R., Bhatt, H.G. et al. A search for potential anti-HIV phytoconstituents from the natural product repository. ADV TRADIT MED (ADTM) 23, 953–984 (2023). https://doi.org/10.1007/s13596-022-00646-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13596-022-00646-2